Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.

Mesalam AA, Desombere I, Farhoudi A, Van Houtte F, Verhoye L, Ball J, Dubuisson J, Foung SKH, Patel AH, Persson MAA, Leroux-Roels G, Meuleman P.

Virology. 2018 Jan 15;514:30-41. doi: 10.1016/j.virol.2017.10.019. Epub 2017 Nov 10.

2.

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.

Desombere I, Mesalam AA, Urbanowicz RA, Van Houtte F, Verhoye L, Keck ZY, Farhoudi A, Vercauteren K, Weening KE, Baumert TF, Patel AH, Foung SKH, Ball J, Leroux-Roels G, Meuleman P.

Antiviral Res. 2017 Dec;148:53-64. doi: 10.1016/j.antiviral.2017.10.015. Epub 2017 Oct 23.

3.

Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma.

Sayed IM, Foquet L, Verhoye L, Abravanel F, Farhoudi A, Leroux-Roels G, Izopet J, Meuleman P.

Antiviral Res. 2017 May;141:150-154. doi: 10.1016/j.antiviral.2017.02.011. Epub 2017 Feb 21.

PMID:
28232247
4.

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.

Khera T, Todt D, Vercauteren K, McClure CP, Verhoye L, Farhoudi A, Bhuju S, Geffers R, Baumert TF, Steinmann E, Meuleman P, Pietschmann T, Brown RJ.

Antiviral Res. 2017 Mar;139:129-137. doi: 10.1016/j.antiviral.2017.01.001. Epub 2017 Jan 3.

5.

Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.

Sayed IM, Verhoye L, Cocquerel L, Abravanel F, Foquet L, Montpellier C, Debing Y, Farhoudi A, Wychowski C, Dubuisson J, Leroux-Roels G, Neyts J, Izopet J, Michiels T, Meuleman P.

Gut. 2017 May;66(5):920-929. doi: 10.1136/gutjnl-2015-311109. Epub 2016 Mar 22.

PMID:
27006186
6.

Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.

Desombere I, Fafi-Kremer S, Van Houtte F, Pessaux P, Farhoudi A, Heydmann L, Verhoye L, Cole S, McKeating JA, Leroux-Roels G, Baumert TF, Patel AH, Meuleman P.

Hepatology. 2016 Apr;63(4):1120-34. doi: 10.1002/hep.28428. Epub 2016 Feb 22.

PMID:
26710081
7.

HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice.

Prentoe J, Verhoye L, Velázquez Moctezuma R, Buysschaert C, Farhoudi A, Wang R, Alter H, Meuleman P, Bukh J.

Gut. 2016 Dec;65(12):1988-1997. doi: 10.1136/gutjnl-2015-310300. Epub 2015 Nov 20.

8.

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.

Vercauteren K, Brown RJ, Mesalam AA, Doerrbecker J, Bhuju S, Geffers R, Van Den Eede N, McClure CP, Troise F, Verhoye L, Baumert T, Farhoudi A, Cortese R, Ball JK, Leroux-Roels G, Pietschmann T, Nicosia A, Meuleman P.

Gut. 2016 Dec;65(12):2029-2034. doi: 10.1136/gutjnl-2014-309045. Epub 2015 Aug 25.

PMID:
26306759
9.

A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.

Meuleman P, Catanese MT, Verhoye L, Desombere I, Farhoudi A, Jones CT, Sheahan T, Grzyb K, Cortese R, Rice CM, Leroux-Roels G, Nicosia A.

Hepatology. 2012 Feb;55(2):364-72. doi: 10.1002/hep.24692. Epub 2011 Dec 16.

10.

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.

Meuleman P, Bukh J, Verhoye L, Farhoudi A, Vanwolleghem T, Wang RY, Desombere I, Alter H, Purcell RH, Leroux-Roels G.

Hepatology. 2011 Mar;53(3):755-62. doi: 10.1002/hep.24171. Epub 2011 Feb 11.

11.

Systemic and local reactions of bee venom immunotherapy in Iran.

Bemanian MH, Farhoudi A, Pourpak Z, Gharagozlou M, Movahedi M, Nabavi M, Mozafari H, Mohammadzadeh I, Chavoshzadeh Z, Shirkhoda Z.

Iran J Allergy Asthma Immunol. 2007 Dec;6(4):203-6.

12.

Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients.

Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari SR, Gharagozlou M, Movahedi M, Purpak Z, Mirsaeid Ghazi B, Mahmoudi M, Farhoudi A.

Pediatr Neurol. 2007 Jul;37(1):21-8.

PMID:
17628218
13.

The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia.

Rezaei N, Moin M, Pourpak Z, Ramyar A, Izadyar M, Chavoshzadeh Z, Sherkat R, Aghamohammadi A, Yeganeh M, Mahmoudi M, Mahjoub F, Germeshausen M, Grudzien M, Horwitz MS, Klein C, Farhoudi A.

J Clin Immunol. 2007 Sep;27(5):525-33. Epub 2007 Jun 21.

PMID:
17587155
14.

Wheat anaphylaxis in children.

Pourpak Z, Ghojezadeh L, Mansouri M, Mozaffari H, Farhoudi A.

Immunol Invest. 2007;36(2):175-82.

PMID:
17365018
15.

High doses intravenous immunoglobulin versus oral cyclosporine in the treatment of severe atopic dermatitis.

Bemanian MH, Movahedi M, Farhoudi A, Gharagozlou M, Seraj MH, Pourpak Z, Nabavi M, Aghamohammadi A, Shirkhoda Z.

Iran J Allergy Asthma Immunol. 2005 Sep;4(3):139-43.

16.

Descriptive study of 226 patients with allergic rhinitis and asthma in karaj city.

Farhoudi A, Razavi A, Chavoshzadeh Z, Heidarzadeh M, Bemanian MH, Nabavi M.

Iran J Allergy Asthma Immunol. 2005 Jun;4(2):99-101.

17.

Recurrent infections and bilateral uveitis in a patient with CD8 deficiency.

Farhoudi A, Chavoshzadeh Z, Mir Saeid Ghazi B, Aghamohammadi A, Gharagozlou M.

Iran J Allergy Asthma Immunol. 2005 Mar;4(1):43-5.

18.

Chronic mucocutaneous candidiasis; report of three cases with different phenotypes.

Fazlollahi MR, Farhoudi A, Movahedi M, Gharagozlou M, Mohammadi K, Rezaei N.

Iran J Allergy Asthma Immunol. 2005 Mar;4(1):39-42.

19.

A study of malnutrition in Iranian patients with primary antibody deficiency.

Kouhkan A, Pourpak Z, Moin M, Dorosty AR, Safaralizadeh R, Teimorian S, Farhoudi A, Aghamohammadi A, Mesdaghi M, Kazemnejad A.

Iran J Allergy Asthma Immunol. 2004 Dec;3(4):189-96.

20.

Screening of the Bruton Tyrosine Kinase (BTK) Gene Mutations in 13 Iranian Patients with Presumed X-Linked Agammaglobulinemia.

Aghamohammadi A, Parvaneh N, Kanegana H, Moin M, Amirzargar AA, Farhoudi A, Pourpak Z, Movahedi M, Gharagozlou M, Rezaei N, Futatani T, Miyawaki T.

Iran J Allergy Asthma Immunol. 2004 Dec;3(4):175-9.

21.

Gastrointestinal manifestations of patients with chronic granulomatous disease.

Movahedi M, Aghamohammadi A, Rezaei N, Farhoudi A, Pourpak Z, Moin M, Gharagozlou M, Mansouri D, Arshi S, Atarod L, Mirsaeid Ghazi B, Shahnavaz N, Babaei Jandaghi A, Abolmaali K, Mahmoudi M, Bazargan N, Ahmadi Afshar A, Nabavi M.

Iran J Allergy Asthma Immunol. 2004 Jun;3(2):83-7.

22.

Neutropenia in patients with primary antibody deficiency disorders.

Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Gharagozlou M, Movahedi M, Mirsaeid Ghazi B, Atarod L, Mahmoudi M, Ahmadi Afshar A, Bazargan N, Isaeian A, Nabavi M, Chavoshzadeh Z, Heydarzadeh M, Bemanian MH, Fazlollahi MR.

Iran J Allergy Asthma Immunol. 2004 Jun;3(2):77-81.

23.

ATM Gene Mutations Detection in Iranian Ataxia-Telangiectasia Patients.

Sanati MH, Bayat B, Aleyasin A, Atashi Shirazi H, Isaian A, Farhoudi A, Moin M.

Iran J Allergy Asthma Immunol. 2004 Jun;3(2):59-63.

24.

Clinical and laboratory findings in Iranian children with cyclic neutropenia.

Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Ramyar A, Moin M, Gharagozlou M, Movahedi M, Mohammadpour B, Mirsaeid Ghazi B, Izadyar M, Mahmoudi M.

Iran J Allergy Asthma Immunol. 2004 Mar;3(1):37-40.

25.

Mortality in primary immunodeficient patients, registered in Iranian primary immunodeficiency registry.

Mir Saeid Ghazi B, Aghamohammadi A, Kouhi A, Farhoudi A, Moin M, Rezaei N, Shahriar Doost P, Movahedi M, Gharagozlou M, Pourpak Z, Arshi S, Yazdani F, Atarod L, Mohammad Zadeh I, Bazargan N, Ahmadi Afshar A, Mahmoudi M, Tahaei A.

Iran J Allergy Asthma Immunol. 2004 Mar;3(1):31-6.

26.

Report of six cases of chediak-higashi syndrome with regard to clinical and laboratory findings.

Farhoudi A, Chavoshzadeh Z, Pourpak Z, Izadyar M, Gharagozlou M, Movahedi M, Aghamohamadi A, Mirsaeid Ghazi B, Moin M, Rezaei N.

Iran J Allergy Asthma Immunol. 2003 Dec;2(4):189-92.

27.

Adverse effects of intravenous immunoglobulin therapy in patients with antibody deficiency.

Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Nikzad M, Movahedi M, Gharagozlou M, Atarod L, Ahmadi Afshar A, Bazargan N, Abolmaali K, Mahmoudi M.

Iran J Allergy Asthma Immunol. 2003 Sep;2(3):121-6.

28.

The comparison of conventional and w.h.o. Methods for protein determination of chenopodium album allergenic extract.

Mousavi T, Movahedi M, Asadi N, Farhoudi A, Moin M.

Iran J Allergy Asthma Immunol. 2003 Jun;2(2):107-9.

29.

A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10-year period (1990-2000), in children hospital medical center.

Atarod L, Raissi A, Aghamohammadi A, Farhoudi A, Khodadad A, Moin M, Pourpak Z, Movahedi M, Charagozlou M, Rezaei N.

Iran J Allergy Asthma Immunol. 2003 Jun;2(2):75-9.

30.

Two related cases of primary complement deficiencies.

Farhoudi A, Bazargan N, Pourpak Z, Mahmoudi M.

Iran J Allergy Asthma Immunol. 2003 Jun;2(2):69-74.

31.

Respiratory manifestations of chronic granulomatous disease; a clinical survey of patients from Iranian primary immunodeficiency registry.

Movahedi M, Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Gharagozlou M, Mansouri D, Babaei Jandaghi A, Shahnavaz N, Rezaei N, Abolmaali K, Alizadeh Arasi Sh, Bakhshaei J, Vaziri M.

Iran J Allergy Asthma Immunol. 2003 Mar;2(1):45-51.

32.

Para Vertebral Abscess and Rib Osteomyelitis due to Aspergillous Fumigatus in a Patient with Chronic Granulomatous Disease.

Farhoudi A, Siadati A, Atarod L, Tabatabaei P, Mamishi S, Khotaii G, Armin Sh, Shirvani F.

Iran J Allergy Asthma Immunol. 2003 Mar;2(1):13-5.

33.

Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases).

Movahedi M, Entezari N, Pourpak Z, Mamishi S, Chavoshzadeh Z, Gharagozlou M, Mir-Saeeid-Ghazi B, Fazlollahi MR, Zandieh F, Bemanian MH, Farhoudi A, Aghamohammadi A.

J Clin Immunol. 2007 May;27(3):302-7. Epub 2007 Feb 10. Erratum in: J Clin Immunol. 2008 Jan;28(1):92. Aghamohammadi, Asghar [added].

PMID:
17294145
34.

Study of alpha1-antitrypsin phenotypes frequencies in patients with primary antibody deficiency.

Fazlollahi MR, Aghamohammadi A, Hosseini RF, Lotfi AS, Khoshdel A, Farhoudi A, Movahedi M, Gharagozlou M, Mozaffari H, Zandieh F, Mansouri M, Ghaffari J, Rezaei N.

Iran J Allergy Asthma Immunol. 2006 Jun;5(2):69-74.

35.

DNA banking of primary immunodeficiency disorders in iran.

Isaian A, Moin M, Pourpak Z, Rezaei N, Aghamohammadi A, Movahedi M, Gharagozlou M, Ghaffari J, Zandieh F, Mansouri M, Farhoudi A.

Iran J Allergy Asthma Immunol. 2006 Dec;5(4):201-2.

36.

Cutaneous manifestations of primary immunodeficiency diseases in children.

Moin A, Farhoudi A, Moin M, Pourpak Z, Bazargan N.

Iran J Allergy Asthma Immunol. 2006 Sep;5(3):121-6.

37.

Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry.

Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, Atarod L, Ghazi BM, Isaeian A, Mahmoudi M, Abolmaali K, Mansouri D, Arshi S, Tarash NJ, Sherkat R, Akbari H, Amin R, Alborzi A, Kashef S, Farid R, Mohammadzadeh I, Shabestari MS, Nabavi M, Farhoudi A.

J Clin Immunol. 2006 Nov;26(6):519-32. Epub 2006 Oct 6.

PMID:
17024564
38.

The clinical and laboratory survey of Iranian patients with hyper-IgE syndrome.

Moin M, Farhoudi A, Movahedi M, Rezaei N, Pourpak Z, Yeganeh M, Gharagozlou M, Mirsaeid Ghazi B, Arshi S, Mansouri D, Sherkat R, Kashef S, Mahmoudi M, Nabavi M, Aghamohammadi A.

Scand J Infect Dis. 2006;38(10):898-903.

PMID:
17008235
39.

Pulmonary complications in primary hypogammaglobulinemia: a survey by high resolution CT scan.

Gharagozlou M, Ebrahimi FA, Farhoudi A, Aghamohammadi A, Bemanian MH, Chavoshzadeh Z, Heidarzadeh M, Mehdizadeh M, Moin M, Movahedi M, Nabavi M, Pourpak Z, Rezaei N.

Monaldi Arch Chest Dis. 2006 Jun;65(2):69-74.

PMID:
16913576
40.

Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry.

Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, Mirsaeid Ghazi B, Atarod L, Abolmaali K, Mahmoudi M, Mansouri D, Arshi S, Tarash NJ, Sherkat R, Amin R, Kashef S, Hosseini RF, Mohammadzadeh I, Shabestari MS, Nabavi M, Moin M.

Am J Reprod Immunol. 2006 Aug;56(2):145-51.

PMID:
16836617
41.

Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency.

Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, Chavoshzadeh Z, Jadid L, Rezaei N, Moin M.

J Microbiol Immunol Infect. 2006 Apr;39(2):114-20.

PMID:
16604243
42.

Distribution of primary immunodeficiency disorders diagnosed in the Children's Medical Center in Iran.

Farhoudi A, Aghamohammadi A, Moin M, Rezaei N, Pourpak Z, Movahedi M, Gharagozlou M, Amir Tahaei S, MirSaeid Ghazi B, Mahmoudi M, Kouhi A, Atarod L, Ahmadi Afshar A, Bazargan N, Isaeian A.

J Investig Allergol Clin Immunol. 2005;15(3):177-82.

PMID:
16261953
43.

Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients.

Rezaei N, Farhoudi A, Ramyar A, Pourpak Z, Aghamohammadi A, Mohammadpour B, Moin M, Gharagozlou M, Movahedi M, Ghazi BM, Izadyar M, Mahmoudi M.

J Pediatr Hematol Oncol. 2005 Jul;27(7):351-6.

PMID:
16012323
44.

Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency.

Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, Yaseri N, Movahedi M, Gharagozlou M, Zandieh F, Yazadni F, Arshi S, Mohammadzadeh I, Ghazi BM, Mahmoudi M, Tahaei S, Isaeian A.

Clin Diagn Lab Immunol. 2005 Jul;12(7):825-32.

45.

Which cereal is a suitable substitute for wheat in children with wheat allergy?

Pourpak Z, Mesdaghi M, Mansouri M, Kazemnejad A, Toosi SB, Farhoudi A.

Pediatr Allergy Immunol. 2005 May;16(3):262-6.

PMID:
15853958
46.

Neutropenia in Iranian patients with primary immunodeficiency disorders.

Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, Gharagozlou M.

Haematologica. 2005 Apr;90(4):554-6.

47.

Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry.

Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, Jandaghi AB, Farhoudi A, Pourpak Z, Moin M, Gharagozlou M, Mansouri D.

Int Arch Allergy Immunol. 2004 Jul;134(3):253-9. Epub 2004 Jun 1.

PMID:
15178896
48.

X-linked agammaglobulinemia: a survey of 33 Iranian patients.

Moin M, Aghamohammadi A, Farhoudi A, Pourpak Z, Rezaei N, Movahedi M, Gharagozlou M, Ghazi BM, Zahed A, Abolmaali K, Mahmoudi M, Emami L, Bashashati M.

Immunol Invest. 2004 Feb;33(1):81-93.

PMID:
15015835
49.

The role of cow milk allergy in increasing the severity of atopic dermatitis.

Pourpak Z, Farhoudi A, Mahmoudi M, Movahedi M, Ghargozlou M, Kazemnejad A, Eslamnoor B.

Immunol Invest. 2004 Feb;33(1):69-79.

PMID:
15015834
50.

Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia.

Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, Gharagozlou M, Nabavi M, Shahrokhi A.

FEMS Immunol Med Microbiol. 2004 Mar 8;40(2):113-8.

Supplemental Content

Loading ...
Support Center